199 related articles for article (PubMed ID: 6692408)
1. Level of a membrane-bound high-molecular-weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma.
Giacomini P; Veglia F; Cordiali Fei P; Rehle T; Natali PG; Ferrone S
Cancer Res; 1984 Mar; 44(3):1281-7. PubMed ID: 6692408
[TBL] [Abstract][Full Text] [Related]
2. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis.
Kageshita T; Kuriya N; Ono T; Horikoshi T; Takahashi M; Wong GY; Ferrone S
Cancer Res; 1993 Jun; 53(12):2830-3. PubMed ID: 8504426
[TBL] [Abstract][Full Text] [Related]
3. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
[TBL] [Abstract][Full Text] [Related]
4. Antigenic heterogeneity of skin tumors of nonmelanocyte origin: analysis with monoclonal antibodies to tumor-associated antigens and to histocompatibility antigens.
Natali PG; Viora M; Nicotra MR; Giacomini P; Bigotti A; Ferrone S
J Natl Cancer Inst; 1983 Sep; 71(3):439-47. PubMed ID: 6577218
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions.
Kageshita T; Nakamura T; Yamada M; Kuriya N; Arao T; Ferrone S
Cancer Res; 1991 Mar; 51(6):1726-32. PubMed ID: 1671829
[TBL] [Abstract][Full Text] [Related]
6. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens.
Natali PG; Bigotti A; Cavaliere R; Nicotra MR; Ferrone S
J Natl Cancer Inst; 1984 Jul; 73(1):13-24. PubMed ID: 6376904
[TBL] [Abstract][Full Text] [Related]
7. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
8. Double determinant immunoassay to measure a human high-molecular-weight melanoma-associated antigen.
Giacomini P; Ng AK; Kantor RR; Natali PG; Ferrone S
Cancer Res; 1983 Aug; 43(8):3586-90. PubMed ID: 6344987
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous expression of melanoma-associated antigens and HLA antigens by primary and multiple metastatic lesions removed from patients with melanoma.
Natali P; Bigotti A; Cavaliere R; Liao SK; Taniguchi M; Matsui M; Ferrone S
Cancer Res; 1985 Jun; 45(6):2883-9. PubMed ID: 3157450
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
[TBL] [Abstract][Full Text] [Related]
12. Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1.
Chattopadhyay P; Kaveri SV; Byars N; Starkey J; Ferrone S; Raychaudhuri S
Cancer Res; 1991 Nov; 51(22):6045-51. PubMed ID: 1933867
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of anti HMW.MAA antibodies in sera of melanoma patients using antiidiotypic monoclonal antibodies].
Nakamura T; Kageshita T; Arao T; Yamazaki N; Ishihara K
Nihon Hifuka Gakkai Zasshi; 1990 Oct; 100(11):1121-6. PubMed ID: 2273574
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
15. Measurement of a monoclonal antibody-defined, melanoma-associated antigen in human sera: correlation of circulating antigen levels with tumor burden.
Morgan AC; Crane MM; Rossen RD
J Natl Cancer Inst; 1984 Feb; 72(2):243-9. PubMed ID: 6582312
[TBL] [Abstract][Full Text] [Related]
16. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
Murray JL; Gillogly M; Kawano K; Efferson CL; Lee JE; Ross M; Wang X; Ferrone S; Ioannides CG
Cancer Res; 2004 Aug; 64(15):5481-8. PubMed ID: 15289358
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants.
Giacomini P; Natali P; Ferrone S
J Immunol; 1985 Jul; 135(1):696-702. PubMed ID: 2582052
[TBL] [Abstract][Full Text] [Related]
18. Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions.
Natali PG; Cavaliere R; Bigotti A; Nicotra MR; Russo C; Ng AK; Giacomini P; Ferrone S
J Immunol; 1983 Mar; 130(3):1462-6. PubMed ID: 6600484
[TBL] [Abstract][Full Text] [Related]
19. A cytoplasmic human melanoma associated antigen as a marker of activation in lymphoid cells.
Giacomini P; Viora M; Tecce R; Knowles DM; Natali PG; Ferrone S
Cancer Res; 1987 Oct; 47(19):5175-80. PubMed ID: 3497718
[TBL] [Abstract][Full Text] [Related]
20. Immunoassay for melanoma-associated proteoglycan in the sera of patients using monoclonal and polyclonal antibodies.
Ross AH; Herlyn M; Ernst CS; Guerry D; Bennicelli J; Ghrist BF; Atkinson B; Koprowski H
Cancer Res; 1984 Oct; 44(10):4642-7. PubMed ID: 6380710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]